Company profile
Jiva.Ai Limited
Jiva.ai - Low Code AI Platform - Next Gen Multimodal AI - Create, Test, Validate Deploy
Jiva Auto ML/AI Multimodal Platform allows you to create multiple AI models using differing AI techniques (CNN, Bayesian, ANN, Multimodal, RFT) which can then be tested and deployed.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MzU4MzA2MGFkaXF6a2N4
Published 15 Nov 2024 03:11
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MTQyNjE1NmFkaXF6a2N4
Published 30 Oct 2024 10:25
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
GM Advanced Diagnostics Accelerator (ADA) - Extension
1 Apr 2025 to 31 Mar 2026
The understanding of disease mechanisms is advancing rapidly, leading to innovations which enable earlier and more accurate detection, diagnosis and prognostication, including ruling-out disease in those who can be safely reassured. This gives opportunities for better population health and targeted care pathways bespoke to individuals. However, there rema...
Developing tools for pre-market evaluation and post-market surveillance of Medical Imaging AI
1 Jan 2024 to 31 Dec 2024
AI tools have shown promise in being able to analyse medical imaging and aid healthcare professionals with their image interpretation speed and accuracy. However, the uptake of these algorithms by healthcare organisations has been slow for several reasons including: ● Lack of independent clinical testing about the accuracy of the algorithms. ● Lack of tra...
Joint collaboration to develop a predictive method for preventive medicine in asthma care
1 Nov 2023 to 31 Oct 2025
Asthma management is a significant burden on healthcare systems globally. Billions of dollars are spent on management of the disease when it is too late, with the patient requiring treatment in secondary care. The development of remote technology has improved dramatically in recent years, generating large amounts of data that could aid in predicting the o...
GM Advanced Diagnostics Accelerator
1 Apr 2023 to 31 Mar 2025
no public description
Integrated Diagnostics for Early Diagnosis of Liver Disease [ID-LIVER]
1 Sep 2020 to 31 Aug 2023
Liver disease is an epidemic with up to four in ten people having health problems from their liver not working properly. A proportion of these patients develop scarring that is most commonly picked up late but which can progress without stopping to complete liver failure. It is one of the UK's largest health challenges for which we do not have answers. At...